PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
145.00
-6.00 (-3.97%)
May 26, 2026, 4:04 PM WIB

IDX:LABS Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
205,854199,295147,637136,69993,292129,960
Revenue Growth (YoY)
35.11%34.99%8.00%46.53%-28.21%-
Cost of Revenue
123,388120,09790,88282,13556,13680,529
Gross Profit
82,46679,19856,75554,56437,15649,431
Selling, General & Admin
63,57158,05247,41248,55836,03343,743
Operating Expenses
64,35058,83247,80348,72033,75846,240
Operating Income
18,11620,3668,9525,8443,3983,191
Interest Expense
-1,092-1,246-3,041-2,153-1,554-112.31
Interest & Investment Income
348.79299.31212.161.9523.7463.25
Earnings From Equity Investments
----1,122-
Currency Exchange Gain (Loss)
-781.63-1,275-1,289501.88-1,203-906.66
Other Non Operating Income (Expenses)
230.27116.53315.581,093-72.19245.6
EBT Excluding Unusual Items
16,82218,2615,1505,2871,7132,481
Gain (Loss) on Sale of Investments
---882.29--
Gain (Loss) on Sale of Assets
-738.75-738.75139.9361.822,814201.48
Pretax Income
16,08317,5225,2906,2314,5282,682
Income Tax Expense
4,0154,0152,3374,0411,6932,374
Earnings From Continuing Operations
12,06813,5072,9522,1902,834308.25
Minority Interest in Earnings
0.060.04-0.020.020-
Net Income
12,06813,5072,9522,1902,834308.25
Net Income to Common
12,06813,5072,9522,1902,834308.25
Net Income Growth
211.60%357.50%34.84%-22.75%819.43%-
Shares Outstanding (Basic)
3,9503,9503,9502,354--
Shares Outstanding (Diluted)
3,9503,9503,9502,354--
Shares Change (YoY)
--67.78%---
EPS (Basic)
3.063.420.750.93--
EPS (Diluted)
3.063.420.750.93--
EPS Growth
211.60%357.50%-19.63%---
Free Cash Flow
-19.698,681-20,490-34,233-18,327-32,341
Free Cash Flow Per Share
-0.012.20-5.19-14.54--
Gross Margin
40.06%39.74%38.44%39.91%39.83%38.04%
Operating Margin
8.80%10.22%6.06%4.28%3.64%2.46%
Profit Margin
5.86%6.78%2.00%1.60%3.04%0.24%
Free Cash Flow Margin
-0.01%4.36%-13.88%-25.04%-19.65%-24.88%
EBITDA
30,03533,00721,11415,40212,18711,009
EBITDA Margin
14.59%16.56%14.30%11.27%13.06%8.47%
D&A For EBITDA
11,91912,64112,1629,5598,7897,818
EBIT
18,11620,3668,9525,8443,3983,191
EBIT Margin
8.80%10.22%6.06%4.28%3.64%2.46%
Effective Tax Rate
24.97%22.91%44.19%64.86%37.40%88.51%
Advertising Expenses
-1,4611,1541,123244.61,268
Source: S&P Global Market Intelligence. Standard template. Financial Sources.